Allurion Technologies’ Post

▪️weight loss without losing muscle mass▪️

Effect of timed dosing of usual #antihypertensives according to patient chronotype on #cardiovascular outcomes: the Chronotype sub-study cohort of the Treatment in Morning versus Evening (TIME) study

🩺 Learn about atrial fibrillation, its prevention, and management strategies in our latest blog post. Atrial fibrillation, a common heart rhythm disorder, can increase the risk of stroke and heart failure. Discover essential tips on lifestyle changes, medications, and medical procedures to manage this condition effectively. Equip yourself with knowledge to prevent complications and improve your heart health. Stay informed and take proactive steps to maintain a healthy heart. Read more on our blog. 💓 #Arrhythmia #Cardiology #Electrophysiology #HeartDisease #HeartHealth

🔬 TRIM-AF Trial: Lifestyle Interventions Shine in Atrial Fibrillation Management The TRIM-AF (Targeting Risk Interventions and Metformin for Atrial Fibrillation) trial, presented at the AHA Scientific Sessions 2024, explored the effects of lifestyle/risk factor modification (LRFM) and metformin on atrial fibrillation (AF) progression. While metformin showed no significant benefits, lifestyle changes emerged as a key factor in improving AF symptoms. 🌟 Key Findings 1. Lifestyle Modifications Drive Symptom Relief: • Patients undergoing LRFM reported significant improvements in AF symptom scores compared to those receiving standard care, despite no measurable reduction in AF burden. 2. No Added Benefit of Metformin: • Metformin did not reduce AF burden and, in some instances, appeared less effective than standard care. 3. Primary Endpoint: • No significant differences in AF burden or mortality across all intervention arms. 💡 Clinical Implications • Lifestyle as a Pillar of AF Management: This trial reinforces that lifestyle and risk factor modifications (e.g., weight loss, physical activity, blood pressure control) can significantly improve AF symptoms and overall patient well-being. • Patient Empowerment: Simple, practical interventions can lead to meaningful improvements, emphasizing the importance of empowering patients to actively manage their condition. • Beyond Medication: While pharmacological options remain essential, integrating lifestyle interventions into standard care is crucial for comprehensive AF management. ✨ Conclusion The TRIM-AF trial highlights the transformative potential of lifestyle modifications in managing atrial fibrillation. By improving symptoms and enhancing quality of life, these findings advocate for a patient-centered approach that prioritizes sustainable lifestyle changes alongside medical therapies. #AHA2024 #TRIMAF #AtrialFibrillation #LifestyleMedicine #RiskFactorModification #PatientCenteredCare #Cardiology

Understand the most fundamental function that Photobiomodulation does to us and help improve our health. https://lnkd.in/gZaHxhP8 #photobiomodulation #redlighttherapy

With recent research suggesting a link between AMD and cognitive decline, implementing steps to optimize visual function is necessary and urgent. This is an excellent article by Roya Attar, OD, MBA, DHA with details on how to screen, monitor, treat, refer and collaborate with other professionals to improve patient outcomes. #lowvision #maculardegeneration #optometrist #optometrists #practicemanagement https://lnkd.in/gwGr6qKK

MedRhythms, Inc. announces data validating its ‘Musical’ Digital Therapeutic for Chronic Stroke Treatment>> 🎶MedRhythms announced the publication of two studies validating the efficacy, safety, and usability of InTandem™, a FDA-authorized, prescription-only neurorehabilitation system for home use to improve walking and ambulation in adults with chronic stroke. 🎶The InTandem system improves walking by aligning motor movements with the rhythm of music, leading to an automatic matching of movement to the music's beat. This approach offers a personalized, gradual therapy that enhances walking speed and gait quality. 🎶Stroke-related damage to motor control leads to slow, uneven, and energy-demanding walking patterns in stroke survivors. This type of walking increases the risk of falls, health complications, and lowers quality of life. However, increasing walking speed may sometimes worsen walking smoothness and coordination. 🎶The InTandem group showed a significantly larger increase in walking speed compared to the Active Control group (0.14 m/s vs. 0.06 m/s increase, respectively) without increasing risk of falls or adverse events 🎶The study finds that InTandem is a safe and effective way to enhance walking for people in the later stages of recovering from a stroke. It points out InTandem's ability to fill important gaps in post-stroke care by offering an accessible solution to improve mobility and thus improve quality of life 🎶The limitations of the study include its focus on a specific subset of stroke survivors (those with walking speeds between 0.50 m/s and 0.80 m/s - although these were selected as those most likely to benefit), the relatively short intervention period (five weeks), and the lack of a follow-up period to assess long-term effects 🎶Further research was suggested to explore the scalability of these findings, the potential benefits of longer treatment periods, and the durability of the treatment effects #DTx #DigitalHealth 👇Link to further info in comments 

A New Era in Alzheimer’s Diagnosis: p-tau 217 & The Power of EVY Light Breaking News: <<https://lnkd.in/erA_c75a>> The discovery of the p-tau 217 blood test is revolutionizing the way we detect Alzheimer’s disease (AD). With over 90% accuracy, this test is a game-changer, making early diagnosis more accessible and less invasive than ever before! The Power of Early Diagnosis Imagine catching Alzheimer’s in its earliest stages with just a simple blood test. No more costly scans or invasive procedures. Early detection means earlier treatment, giving patients more time to enjoy life’s precious moments. Time is of the essence, and now, we have the tools to act! Enter EVY Light: Your Partner in Cognitive Health With early detection comes the need for effective, non-invasive treatments. That’s where EVY Light shines! EVY Light is a revolutionary, easy-to-use device designed to support cognitive health from the comfort of your home. It’s not just a product; it’s a lifeline for those looking to enhance brain function and potentially slow the progression of neurodegenerative diseases like Alzheimer’s. Perfect Timing, Perfect Solution The timing of this discovery couldn’t be better! As Alzheimer’s cases rise, the demand for accessible, effective treatments like EVY Light grows stronger. We’re proud to be at the forefront of this movement, offering a solution that’s as simple as it is powerful. Shaping the Future of Cognitive Health OptoCeutics is leading the charge in transforming how we approach cognitive decline. The p-tau 217 test and EVY Light together represent a future where early detection and effective treatment go hand in hand. Learn More About EVY Light: <<https://lnkd.in/eTc66Zzn>> #AlzheimersAwareness #CognitiveHealth #EarlyDiagnosis #EVYLight #BrainHealth #Neurodegeneration #AlzheimersResearch #HealthyAging ---- Claims regarding the effectiveness of EVY LIGHT® and 40 Hz light are based on ongoing research and have not been conclusively proven. EVY LIGHT® follows the published guidelines by FDA for low risk general wellness products and is not subject to FDA medical device regulations. EVY LIGHT® is not intended to diagnose, treat, cure, or prevent any diseases or medical conditions.

🌟 Happy to Share! 🌟 Our study on AI in Diabetes Care, conducted by myself, Dr Suman Ramachandra, and Dr. Vijay Kumar, has been highlighted in today's Bangalore Mirror (a part of The Times of India group)! This research emphasizes the transformative potential of AI in delivering personalized and remote diabetes care. 📖 Read the article here: https://shorturl.at/tr2XS Dr Manohar K N #AIinHealthcare #DiabetesCare #KRSSDI #PersonalizedMedicine #ProudMoment

🌐💡 Rethinking Chronic Pain Management in the Digital Age 💡🌐 with Benjamin Lipp In the era of digital health, we're witnessing a surge in innovative tools to tackle chronic pain. 💊💻 From virtual reality therapy to wearables, the potential is vast. But here's a thought: Are we inadvertently leaving some behind in the race towards pain relief? Hear me out: we're at a critical juncture where the marriage of tech and healthcare must prioritize equity. 🤝💙 Rural areas without broadband, older generations navigating digital literacy gaps—let's not overlook them in our quest for a pain-free future. 🔄 Integrative care, not just a buzzword! Chronic pain isn't a one-size-fits-all problem, and neither should be the solution. Digital health pioneers, let's shift the narrative from standalone fixes to collaborative ecosystems. 🌍 💥 Imagine if our digital health solutions weren't just upgrades but transformative connectors in this #Phygital revolution. Let's foster partnerships that bridge the tech-savvy with quality healthcare providers, ensuring everyone, regardless of location or tech literacy, has a seat at the pain management table. 🔗 Digital health's potential is immense, but its true power lies in inclusivity. Let's make the future of pain management one where nobody gets left behind! 🌈 #DigitalHealth #ChronicPain #InclusiveTech #HealthcareInnovation Morgane Donot Lilly Stairs Chronic Boss Collective Meredith Mangold Laure Wasniewski Mackenzie Abramson, MPH Jessica March